Fox Rothschild has been dismissed from a New Jersey state court action brought by a couple who alleged the firm attempted to collect on high-interest loans they said they were unlawfully steered into taking from the firm's litigation funder client.

As reported by Law360, the claim arose from a car accident suit in which a former client alleged he was directed into multiple advances carrying rates so high that he ultimately owed more than his settlement was worth. The couple pursued the firm on an abuse of process theory tied to its role in the collection effort. Fox Rothschild argued its involvement had been limited to a tangential, representative capacity on behalf of its client, and the court accepted that the allegations did not support keeping the firm in the case.

The dismissal narrows a dispute that had drawn attention for testing whether counsel to a funder can be held directly answerable for the terms of the underlying advances. The suit was filed in July, and the firm had moved to exit shortly afterward.

The underlying allegations remain live against the funder itself, and the outcome speaks more to the limits of pleading against outside counsel than to the merits of the pricing complaint. New Jersey has been an active venue for consumer legal funding disputes, with several matters over the past year probing disclosure, rate structures and the relationship between funders and the firms representing claimants.

For the consumer segment, the case is another illustration of how rate and steering allegations are reaching courts even in the absence of a state statute governing the product. New Jersey's legislature has considered funding disclosure measures without enacting one, leaving those questions to be worked out claim by claim.

Aperture Investors has grown its litigation finance platform beyond $600 million in assets, with approximately $1 billion in total investment capacity, marking one of the larger disclosed commitments to law firm lending by an institutional manager this year.

According to Aperture Investors, the strategy provides structured loans primarily to law firms, secured by expected legal fee receivables from matters that are post-settlement, procedurally mature, near settlement or short duration in nature. The approach is designed to generate uncorrelated, income-oriented returns through institutional private credit in what the firm describes as an emerging and historically underbanked asset class.

Luke Darkow, Portfolio Manager for Litigation Finance, leads the platform. He brings more than 13 years of litigation finance investing experience and heads a team with relationships across more than 250 law firms and legal service providers. "Plaintiffs law firms' ability to access traditional debt and equity financing solutions remains relatively constrained, while investors are looking for sources of return that are less dependent on traditional market cycles," Darkow said.

The expansion follows Darkow's arrival from Victory Park Capital in September 2024 to launch the strategy. Aperture, part of Generali Investments, managed approximately $6.72 billion in assets as of June 30, 2026, across alternative credit strategies including asset-based finance and structured credit.

The structure is worth noting for how it differs from case-level funding. Lending against fee receivables from settled or near-settled matters carries duration and counterparty risk rather than the binary outcome risk of a single-case investment, which is precisely the profile institutional credit allocators have found easier to underwrite. As traditional funders contend with slower realisations and tighter capital, the law firm lending segment continues to attract managers whose comfort lies in credit rather than litigation outcomes.

A commentary published this week argues that California's litigation environment functions as an unofficial tax on businesses and consumers, adding to the state's cost of living at a moment when affordability dominates its politics.

As reported by California Globe, the piece by John Allard, a former mayor of Roseville with more than two decades as a small business owner, sets national tort costs at $529 billion in 2022, equivalent to 2.1% of GDP, and cites projections that the figure could exceed $900 billion by 2030. Within California, the author points to 199 nuclear verdicts between 2013 and 2022 totalling more than $9 billion.

Much of the argument focuses on state-specific mechanisms. Allard highlights the Private Attorneys General Act, noting that claims routed through the state review process resolve 52% faster while workers receive 67% less compensation than in court-filed claims, and describes Proposition 65 as having produced an industry of citizen enforcers, with settlements rising from $26 million across 890 settlements in 2022 to more than $101 million across over 1,300 settlements more recently. The commentary also flags the Gilead "duty to innovate" case as an example of novel liability theories reaching the state's highest court.

Third-party litigation funding appears only in passing, referenced in connection with Georgia's 2025 reforms rather than through California-specific data. That absence is itself notable: the state has no funding disclosure or registration statute, and the op-ed offers no estimate of funded case volume within its cost figures.

The piece is advocacy rather than analysis, and its figures come from tort reform sources whose methodology has been contested. It nonetheless illustrates how the cost-of-living frame is being applied to litigation policy in the largest state yet to legislate on funding, and where a disclosure debate has so far failed to gain traction.

London-based Novarex Capital Partners has completed an initial £5 million funding round, with a second round already underway as part of a broader capital programme.

According to ACCESS Newswire, the firm describes itself as a specialist introduction platform focused on private credit, litigation finance and structured capital, identifying opportunities for sophisticated investors seeking access to private markets. The proceeds of the initial round support the working capital requirements of an SRA-regulated law firm engaged in the preparation of eligible claims, operating in accordance with SRA standards and maintaining professional indemnity insurance.

The company said each stage of funding is designed to align with operational requirements while adhering to relevant regulatory frameworks. A second round is advancing, with a further round planned.

The structure reflects a financing model that has become increasingly common in the UK claims market, where capital is deployed against a law firm's working capital needs during claim preparation rather than committed to individual matters. That approach places the funder's exposure at the firm level, tied to the pace at which eligible claims are built and progressed, and depends heavily on the quality of the underlying claim pipeline and the discipline of the regulated firm carrying out the work.

The raise is modest by the standards of the institutional funds that have dominated recent fundraising headlines, but it sits in a segment of the UK market that has drawn scrutiny following a series of failures among smaller funders and claims businesses over the past year. Whether Novarex's staged capital programme reaches its later rounds will offer some indication of investor appetite for law firm working capital exposure at a moment when that risk is under closer examination.

Average payments on U.S. auto bodily injury claims rose at more than double the rate of medical care inflation between 2017 and 2022, according to a new Insurance Research Council study drawn from one of the largest claims datasets assembled for the line.

As reported by Insurance Business, the IRC analysed more than 7.4 million auto injury claims closed with payment over the five-year window, pooled from nine insurers representing roughly 43% of the U.S. private passenger auto market. Average bodily injury claim payments climbed from approximately $14,000 in 2017 to more than $20,000 in 2022, an annualised increase of 7.8% that accelerated markedly after 2020.

The study points to attorney involvement as a central variable. Legal representation among claimants rose from 40% in 2017 to nearly 50% by 2022, with bodily injury claimants showing the sharpest movement at 11 percentage points, while litigation rates nearly doubled from 10% to 18%. Medical bills increasingly functioned as a multiplier rather than a fixed cost: for each dollar of medical expense, total settlement value rose from $1.80 in 2017 to $2.30 by 2022.

The outcomes data complicates the picture for claimants. Represented claimants saw median closure times of 440 days against under 220 days for unrepresented claimants, and after accounting for medical costs and legal fees, netted $1.40 per dollar of medical bills compared with $1.80 for those without representation. IRC's Patrick Schmid tied the trend to settlement pressures and their downstream effect on auto insurance affordability.

The findings arrive as insurers and trade groups press state and federal lawmakers on third-party litigation funding disclosure, and the report's framing of structural cost drivers is likely to feature in that argument. The dataset's scale gives the numbers unusual weight in a debate that has often turned on contested estimates.

LionFish Capital has been admitted as the newest Funder Member of the Association of Litigation Funders of Australia, marking a formal step in the London-based funder's expansion into one of the world's longest-established litigation funding markets.

According to LionFish Capital, the membership reflects a long-term commitment to the Australian market and support for AALF's work advancing best practice, transparency, governance and professionalism across the industry. Founded in 2020 and capitalised by funds managed by an FTSE 250-listed alternatives investment manager, LionFish has built its reputation in the UK on high-value general commercial disputes and on its decision to publish and continually update its template funding documentation.

The Australian push has been reinforced by two senior appointments over the past year: Andrew Saker, former chief executive of ASX-listed Omni Bridgeway, as Strategic Adviser, and Andrew Charles, a senior executive and global investment committee member at Omni Bridgeway for nearly two decades, as Senior Adviser. The firm has indicated its primary focus in Australia will remain high-value general commercial claims, an area it considers underserved despite the market's maturity, while it will also consider class actions given the country's well-developed collective redress regime.

AALF Chief Executive Officer Pip Murphy said the association was delighted to welcome LionFish, describing it as "an innovative and highly respected participant in the litigation funding market" and singling out its published funding documentation as evidence of its transparency commitment. Managing Director Tanya Lansky said Australia represented "a natural extension of the business we have successfully built in the UK," citing the quality of opportunities identified during several visits this year.

The move adds a UK-domiciled funder to the membership of a market where commercial disputes and class actions continue to generate sustained demand for third-party capital.

Illinois Governor JB Pritzker has signed House Bill 5487 into law, placing new limits on the role management services organizations and outside investors may play in the operation of law firms.

As reported by Law360, the legislation bars private equity groups, hedge funds and entities they control from interfering with an attorney's professional judgment, accessing client records or attorney-client communications, selecting or terminating lawyers and legal staff, or setting competency and productivity standards. It also prohibits compensation arrangements tied directly or indirectly to a firm's legal fees, revenues or profits, and voids post-termination non-competition provisions and clauses restricting commentary on service quality or ethical concerns.

The statute reaches attorneys and firms with annual global revenue below $300 million, along with those that regularly represent clients on a contingent fee basis. Firms above that threshold are effectively exempt, a design that concentrates the compliance burden on the mid-market and plaintiff-side segments where MSO structures have proliferated most rapidly. The measure drew support from both the Illinois Trial Lawyers Association and the Illinois Defense Counsel, an unusual alignment of plaintiff and defense interests.

Supporters frame the law as a safeguard for professional independence at a moment when outside capital is entering the legal industry through alternative business structures and service organizations. Critics counter that its scope is broader than the private equity conduct it targets, and that terms such as "indirectly" in the fee-sharing prohibition leave considerable uncertainty for legitimate financing arrangements.

For litigation funders and capital providers building law firm relationships, Illinois now joins a widening group of states drawing statutory lines around who may hold economic influence over a practice. The signature converts a debated proposal into an operating constraint, and firms with existing MSO arrangements in the state will need to test those structures against the new prohibitions.

Innsworth Capital has discontinued the arbitration proceedings it brought against Walter Merricks and accepted £62.6 million plus interest from the £200 million Mastercard settlement, resolving a dispute that had held up compensation to consumers for more than a year.

As reported by Legal Futures, the agreement clears the way for at least £100 million to be distributed to class members, with individual payments expected to range between £45 and £70 depending on how many people come forward. A six-month registration period is set to open shortly, with payments anticipated in the first half of 2027. Innsworth managing director Ian Garrard confirmed the arbitration had been discontinued as part of the resolution of all outstanding issues.

The settlement follows a June ruling in which the Divisional Court rejected Innsworth's judicial review challenge to the distribution formula approved by the Competition Appeal Tribunal. Under that framework, the first £100 million goes to consumers, unclaimed sums pass to the Access to Justice Foundation, and the funder is reimbursed for litigation costs before receiving a return on capital. The Tribunal had earlier declined Innsworth's request for immediate payment of more than £41 million from the settlement fund, holding that any distribution to the funder should await the outcome of the judicial review.

The Tribunal characterised the £200 million outcome as "very far from a success for a class of some 44 million claimants," and treated a 1.5 times return on invested capital as appropriate in light of that result. A nationwide publicity campaign will now alert eligible consumers, principally those over 34 who shopped at UK retailers between May 1992 and June 2008, whether or not they held a Mastercard.

The resolution closes an eight-year saga that became the sector's most visible test of what a funder may claim when a class representative settles for less than the funder expected.